Aarti Drugs Limited (BOM:524348)
374.05
-1.15 (-0.31%)
At close: Jan 21, 2026
Aarti Drugs Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jan '26 Jan 20, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
| 34,213 | 31,240 | 39,886 | 31,280 | 39,725 | 64,755 | Upgrade | |
Market Cap Growth | -18.09% | -21.68% | 27.51% | -21.26% | -38.65% | 449.47% | Upgrade |
Enterprise Value | 39,705 | 36,849 | 45,531 | 36,863 | 44,228 | 67,914 | Upgrade |
Last Close Price | 374.85 | 339.80 | 432.83 | 336.36 | 426.08 | 688.75 | Upgrade |
PE Ratio | 16.38 | 18.58 | 23.27 | 18.81 | 19.38 | 23.09 | Upgrade |
Forward PE | 15.08 | 16.62 | 17.30 | 14.25 | 13.79 | 18.31 | Upgrade |
PS Ratio | 1.38 | 1.31 | 1.58 | 1.15 | 1.60 | 3.01 | Upgrade |
PB Ratio | 2.33 | 2.28 | 3.11 | 2.62 | 3.83 | 7.09 | Upgrade |
P/TBV Ratio | 2.35 | 2.39 | 3.20 | 2.68 | 3.83 | 7.09 | Upgrade |
P/FCF Ratio | 72.70 | 46.33 | 30.08 | - | - | 97.06 | Upgrade |
P/OCF Ratio | 14.95 | 12.77 | 11.11 | 23.46 | 56.42 | 41.79 | Upgrade |
PEG Ratio | 0.66 | 1.44 | 1.44 | 1.44 | 1.53 | 0.39 | Upgrade |
EV/Sales Ratio | 1.60 | 1.54 | 1.80 | 1.36 | 1.78 | 3.15 | Upgrade |
EV/EBITDA Ratio | 12.82 | 12.96 | 14.50 | 12.17 | 13.19 | 15.67 | Upgrade |
EV/EBIT Ratio | 15.78 | 15.93 | 17.18 | 14.44 | 15.34 | 17.50 | Upgrade |
EV/FCF Ratio | 84.37 | 54.65 | 34.34 | - | - | 101.79 | Upgrade |
Debt / Equity Ratio | 0.39 | 0.45 | 0.44 | 0.51 | 0.52 | 0.38 | Upgrade |
Debt / EBITDA Ratio | 1.85 | 2.15 | 1.79 | 1.99 | 1.60 | 0.80 | Upgrade |
Debt / FCF Ratio | 12.19 | 9.12 | 4.26 | - | - | 5.26 | Upgrade |
Asset Turnover | 0.98 | 0.95 | 1.04 | 1.17 | 1.25 | 1.29 | Upgrade |
Inventory Turnover | 3.39 | 3.26 | 3.39 | 3.67 | 3.62 | 3.60 | Upgrade |
Quick Ratio | 0.95 | 0.95 | 0.92 | 0.94 | 0.84 | 0.97 | Upgrade |
Current Ratio | 1.68 | 1.60 | 1.66 | 1.57 | 1.48 | 1.78 | Upgrade |
Return on Equity (ROE) | 14.49% | 12.68% | 13.87% | 14.93% | 21.03% | 35.81% | Upgrade |
Return on Assets (ROA) | 6.24% | 5.77% | 6.83% | 6.89% | 9.07% | 14.52% | Upgrade |
Return on Invested Capital (ROIC) | 10.78% | 9.69% | 10.71% | 11.39% | 15.72% | 26.05% | Upgrade |
Return on Capital Employed (ROCE) | 13.80% | 13.30% | 16.20% | 17.30% | 22.70% | 33.20% | Upgrade |
Earnings Yield | 5.82% | 5.38% | 4.30% | 5.32% | 5.16% | 4.33% | Upgrade |
FCF Yield | 1.38% | 2.16% | 3.32% | -1.01% | -2.05% | 1.03% | Upgrade |
Dividend Yield | 0.27% | 0.29% | 0.23% | 0.30% | 0.24% | 0.36% | Upgrade |
Payout Ratio | 4.55% | 5.39% | 5.41% | 5.65% | 4.64% | 8.28% | Upgrade |
Buyback Yield / Dilution | 5.05% | 0.72% | 0.72% | - | 0.64% | - | Upgrade |
Total Shareholder Return | 5.32% | 1.02% | 0.95% | 0.30% | 0.88% | 0.36% | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.